In Search of Telomeric Fusions in Telomere Mutants of Tetrahymena thermophila by Paul, Arun George
Eukaryon
Volume 2 Article 21
1-1-2006
In Search of Telomeric Fusions in Telomere
Mutants of Tetrahymena thermophila
Arun George Paul
Lake Forest College
Follow this and additional works at: http://publications.lakeforest.edu/eukaryon
Part of the Molecular Biology Commons, and the Structural Biology Commons
Disclaimer:
Eukaryon is published by students at Lake Forest College, who are solely responsible for its content.
The views expressed in Eukaryon do not necessarily reflect those of the College. Articles published
within Eukaryon should not be cited in bibliographies. Material contained herein should be treated
as personal communication and should be cited as such only with the consent of the author.
This Senior Thesis is brought to you for free and open access by Lake Forest College Publications. It has been accepted for inclusion in Eukaryon by an
authorized administrator of Lake Forest College Publications. For more information, please contact levinson@lakeforest.edu.
Eukaryon, Vol. 2, January 2006, Lake Forest College                                                                                     Senior Thesis
86
In Search of Telomeric Fusions in Telomere Mutants of
Tetrahymena thermophila
Arun George Paul*
Department of Biology
Lake Forest College
Lake Forest, Illinois 60045
Summary
The ends of eukaryotic chromosomes are protected
by nucleoprotein structures called telomeres
consisting of GC-rich repeat sequences. Studies
have shown that mutated telomeres are detrimental
to the cell, causing chromosomal fusions and
increased genomic instability (Dandjinou et. al.,
1999). Previous research in our lab on Tetrahymena
thermophila (T. thermophila) has shown a severe
anaphase arrest (Kirk et al., 1997) and extensive
loss of telomere sequences in response to
telomeric DNA mutations. In other eukaryotes,
telomere loss results in telomeric fusions (Tong et.
al., 2001). Therefore, in our telomeric mutants I
hypothesize the existence of telomeric fusions. In
order to test our hypothesis, I developed a
polymerase chain reaction (PCR) assay that can
detect telomere fusions. Primers were designed
from the sequences just adjacent to the telomere
called telomere-associated sequences (TAS). I
designed a positive control to ensure that our
assay could overcome the typical difficulties
encountered in amplifying long GC-rich PCR
products. Clones of T. thermophila TAS sequences
were cut and ligated to mimic potential in vivo
fusion events. PCR on my positive control
demonstrated that our assay can amplify telomeric
fusions up to 841 bp. Preliminary assays of the
mutant DNA did not amplify any fusion products.
However, reamplification of the products from PCR
on digested DNA yielded products. Southern blot
analysis of these products using a telomeric probe
showed signals that indicate fusions. However,
sequence analysis showed the signals to be
artifacts produced by the reamplification. The study
suggests that micronuclear fusions up to 841 bp
may not exit in our mutants and if they do, the
number of such fusion events is beyond the
amplification limit of my assay.
Introduction
The Beginning of the End: The World of Telomeres
Milestones of Telomere History
In the field of modern molecular biology, telomere is a
common word that resonates with the terms ageing and
cancer. By definition, telomeres are the end sections of
chromosomes. Although the era of contemporary
molecular biology starts with Watson and Crick’s
discovery of DNA in the early 50s of the twentieth
century, the history of telomeres goes further back. The
concept of telomeres originated from a set of simple
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genetic experiments in the early part of the twentieth
century by legendary cytologists Herman Muller and
Barbara McClintock in 1938.
The Terminal Gene Hypothesis by Herman Muller
The first person to notice the uniqueness of
chromosomal ends was Herman Muller (Muller, 1938).
When observed under a microscope with high
magnifying power, chromosomes, the genetic material
of cells, appear as linear structures with no apparent
difference at their tips. Muller changed this idea in 1938
through his classical study, which for the first time
created artificial mutation in chromosomes by exposing
fruit flies (Drosophila melanogaster) to X-rays. His
mutants demonstrated several chromosomal
aberrations, such as translocations, deletions, and
reversions throughout the chromosomes, except in the
very ends (Muller, 1938). This intriguing observation led
him to propose that chromosomal ends have a
specialized structure (Muller, 1938). In his classical
lecture at the Woods Hole Marine Biological Laboratory,
he concluded that "... the terminal gene must have a
special function that of sealing the end of the
chromosome, so to speak, and that for some reason a
chromosome cannot persist indefinitely without having
its ends thus sealed." (Muller, 1938).
The Chromosome Healing Hypothesis by Barbara
McClintock
After Muller, Barbara McClintock, another veteran
cytologist and Nobel Laureate further developed the
idea of the specialized chromosomal ends by
demonstrating their potential function as a healer for
aberrations in the ends. In her classical study, she
observed that broken chromosomes fused to form
dicentric chromosomes by a process called breakage-
fusion-bridge cycle (McClintock, 1938). However, to her
surprise the ends of the chromosomes were never
subjected to this process and she called this process
“chromosome healing” (McClintock, 1941). Two
decades later, Muller gave the term ‘telomere’ to the
specialized chromosomal ends (Muller, 1962).
Telomeres and End-Replication Problem
The interest in chromosomal ends or telomeres further
expanded when Olovnikov  (1971) and Watson (1972)
independently proposed the end-replication problem.
DNA polymerases synthesize DNA only in the 5’ to 3’
direction (Alberts, 1997). Therefore, the lagging strand
of the replication fork is created in discontinuous
segments also known as Okasaki fragments, where an
RNA primer initiates each segment formation (Alberts,
1997). However, at telomeric ends, there is no
sequence for the primer to bind and therefore after
each division the chromosomes get shorter (Alberts,
1997). This issue became known as the end-replication
problem (Alberts, 1997) and was fascinating for the
time of Olovnikov and Watson, since, the mechanism
that single-celled organisms and germ cells used to
maintain their chromosome length after each cycle of
replication was unknown. However, the solution that
nature had evolved to solve this problem remained a
mystery for another decade.
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Discovery of Telomeric DNA by Elizabeth Blackburn
Probably the most fascinating part of telomeric history
was the discovery of the uniqueness of telomeric DNA.
In 1978, Elizabeth H. Blackburn and Joseph G. Gall
showed that in T. thermophila, unlike normal DNA
sequences consisting of nucleotides sequences with no
apparent pattern, telomeres consists of short repeats of
GGGGTT (Blackburn and Gall, 1978). After her
discovery, similar results were reported from several
organisms, such as yeast (Shampay and Blackburn,
1984), Arabidopsis thaliana (A. thaliana) (Richards and
Ausubel, 1988), and humans (Moyzis et al., 1988). The
discovery of telomeric DNA by Blackburn, besides
being fascinating for its uniqueness also intrigued
scientists, since it provided an intellectual foundation
upon which novel hypothesizes that explain the end
replication problem can be made.
Research for the last two decades, since the
discovery of telomeric DNA by Blackburn and Gall
(1978) has further expanded our understanding of
telomere structure. By definition, telomeres are now
considered as DNA-protein complexes. Either
component is vital for the proper functioning of the
telomeres.
Telomeric DNA: Studies have shown that telomeric
repeats do not vary much between different species
(McEachern et. al., 2000). For example, a number of
species, such as Aspergillus nidulans (Bhattacharya et.
al., 1997), have the vertebrate telomere sequence
TTAGGG. The reason why there are similar telomere
sequences between diverse species is still an intriguing
aspect of telomeres. Potential explanations include the
conservation of DNA binding domains between the
telomere maintenance proteins of different species
(McEachern et. al., 2000). Although telomeric
sequences are similar between several species, they
can also vary in size and type. The number of telomeric
repeats ranges from several thousands, as in humans,
which consist of ~60,000 TTAGGG sequences, to a few
hundred GGGGTT repeats, as in the macronucleus of
T. thermophila (Kirk and Blackburn, 1995). Another
significant variation observed in telomeric tracts is the
existence of more than one type of repeat in the same
chromosome (McEachern et. al., 2000). For instance,
micronuclear telomeres of T. thermophila have an
internal G4T3 telomeric tract (0.6 -1.0 kb) along with the
external G4T2 tract (1.4 - 2.1 kb; Kirk and Blackburn,
1995). In some cases, such as with Saccharomyces
cerevisiae (S. cerevisiae), Saccharomyces pombe (S.
p o m b e )  (Shampay and Blackburn, 1984) and
Chlorarachinophyte algae (Gilson and McFadden,
1995), the complete set of telomere sequences also
can vary between the chromosomes.
Telomere Protein Components: The protein
components of telomeres, also known as telomeric
proteins, form parts of the telomeric nucleo-protein
complex and are well characterized in humans, mouse,
yeast, and ciliated protozoa (McEachern et. al., 2000).
They are differentiated on the basis of the type binding
to telomeric sequences. The two main classes of
telomeric proteins are the single and double-stranded
DNA binding proteins. They are well characterized in S.
cerevisiae (Klobutcher et. al., 1981; Shore and
Nasmyth, 1987 & Larson et. al., 1994), S. pombe
(Copper et. al., 1997 & Vassetzky et. al., 1999) and
humans (Broccoli et. al., 1997; Chong et. al., 1995).
The significance of these proteins for the stability of
telomere structures (Conrad et. al., 1990), telomere
length regulation (Lustig et. al., 1990; Steensel and de
Lange, 1997), and the requirement of having an optimal
amount of these proteins for telomere maintenance and
stability (Steensel et. al., 1998) has been well
demonstrated.
Discovery of Telomerase by Carol Grieder and
Elizabeth Blackburn
A decade after the discovery of telomeric DNA by
Blackburn (1985), she also formulated the solution to
the end replication along with her graduate student
Carol Grieder by the discovery of the enzyme terminal
transferase (telomerase) in T. thermophila (Grieder and
Blackburn, 1985). They showed that telomerase is a
ribonucleoprotein complex with an RNA template called
telomerase RNA later called TER (Grieder and
Blackburn, 1987) with complimentary sequences to the
respective telomere sequence (Lentz et. al., 1990).
Telomerase uses RNA as the template to synthesize
novel telomere repeats (Fig. 1). The synthesis of
telomeres is conducted by telomerase Reverse
Transcriptase (TERT), the reverse transcriptase that
forms the enzymatic core of the telomerase, which is
characterized in several species, including T.
thermophila (Collins and Gandhi, 1998) and humans
(Lingner et al., 1997 & Nakamura et al., 1997).
Even though eukaryotic telomere length is maintained
by telomerase, non-telomerase based mechanisms or
alternate lengthening of telomeres (ALTs) also exist.
For example, both S. cerevisiae (Lundblad and
Blackburn, 1993 & Mangahas et. al., 2001) and K.
Lactis (McEachern and Blackburn, 1996) is shown to
maintain their telomeres without telomerase through
chromosomal recombination pathways (Bechter et. al.,
2003). Another example is Drosophila melanogaster,
where telomeres are extended by insertion of specific
DNA sequences called retro-transposons (Biessmann
and Mason, 1997).
The Telomeres-Ageing-Cancer Connection
The link between telomeres, telomerase, and the end-
replication problem also resulted in the formulation of
novel ideas regarding ageing and cellular immortality.
Ageing refers to the limited replicative potential of the
cell. This phenomenon was first demonstrated by
Hayflick and Moorehead (1961) in skin fibroblast cells,
which had a replicative potential of 50 cell divisions. In
1989, the connection between telomeres and ageing
was first demonstrated in S. cerevisiae, where a defect
in telomere elongation resulted in cellular senescence
(Lundblad and Szostak, 1989). The study showed that
in the absence of telomerase, chromosomes shortened
after each cycle of replication and lead to chromosome
instability that subsequently activates the programmed
cell death machinery (Lundblad and Szostak, 1989).
Cancer refers to uncontrolled cell growth or
the ability of the cells to bypass ageing. Conceptually,
cells with active telomerase will maintain their telomere
length and will therefore be immortal. In fact, several
studies have demonstrated that cells will become
immortal and cancerous, when telomerase is active
(Grieder, 1998; Multani et. al., 1999). In general,
telomerase is inactive in all somatic cells (Harley et. al.,
1990; Kim et al., 1994) and therefore their telomeres
will shorten as we age (Allsopp et al., 1992). The
exceptions  are germ  line cells  (Kim et al., 1994)    and
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Figure 1.  Model for Telomere repeat addition by T. thermophila telomerase
The structure of telomerase consists of TER (RNA component) and TERT (catalytic core). The TERT acts us a reverse transcriptase and
uses the TER for the de novo addition of telomeric repeats using the telomerase RNA template (picture by Kirk (1996).
embryonic cells (Kilian et al., 1998) that need to
maintain their telomere length. Many scientists also
propose that telomerase activity is an excellent marker
for certain type of cancers (McKenzie et. al., 1999).
Interestingly, this topic has been further investigated
due to the recent discovery of shortened telomeres and
their corresponding shortened life spans in cloned
organisms (Shiels et. al., 1999).
Discovery of the D-Loop-T-Loop
After the discovery of telomeric DNA, telomerase, and
consequently the revelation of the telomere-ageing-
cancer connection, one of the most fascinating
discoveries of chromosome biology is the telomere-loop
or t-loop. The first hint for this discovery came from
Henderson and Blackburn (1989), who showed that the
end of T. thermophila telomeres consists of a 3’ single
stranded overhang. In humans, the G-overhang
consists of 75-300 bp of TTAGGG repeats (Wright et.
al., 1999). A decade later, the examination of telomere
structure using electron microscopy by Griffith and de
Lange (1999) showed that the very end of telomeres
form a large loop of ~10-20 kb. The study also showed
that the 3’ overhang of the telomere invades the double
stranded DNA and base pairs with a homologous
telomeric strand to form a smaller loop (~100-200 bp)
called the D-loop (Fig. 2; adapted from Grieder, 1999).
Further studies have revealed that the D-loop provides
a binding site for the telomere binding protein TRF2 and
stabilizes the loop structure (Grieder, 1999).
Structurally, the present model proposes that both the t-
loop and the D-loop provide binding sites for several
telomere-binding proteins (Grieder, 1999).
The discovery of the t-loop with proteins bound to it was
so profound that it immediately proposed an
architectural model to the mechanisms that protected
telomeres from being degraded or fused. The model
also explained how telomere shortening is linked to
senescence and apoptosis (Evans and Lunblad, 2000).
When telomere length becomes shorter than the
minimal amount (~300-500 bp) to form the t-loop,
proteins like TRF1 and TRF2 will not bind to it. This, in
turn will expose the free telomeric ends to DNA
degradation (Evans and Lunblad, 2000), which can lead
to apoptosis in a p53-dependent DNA-damage
response pathway (Evans and Lunblad, 1999).
Although the discovery of the t-loop-D-loop
was intriguing, classical telomere biology was explained
completely on the basis of linear telomeres.
Conceptually, therefore it was necessary to propose a
mechanism that exposed telomeres to telomerase by
uncapping the telomere protein-loop structure (Grieder,
1999). The present model suggests that the t-loop
complex and its proteins exist as a feedback system
that regulates telomere length by controlling the
availability of telomeres to telomerase (Dubrana et. al.,
2001). The model proposes the existence of two
physical states for telomeres—a closed and open state
(Dubrana et. al., 2001). During the open state, DNA-
binding proteins in general forms a high order complex
that prevent the accessibility of telomeres to telomerase
and vice-versa in closed state (Dubrana et. al., 2001).
The Puzzle of Double-Strand Breaks
Although, several of the telomere puzzles have been
resolved, there is one that still fascinates and haunts
telomere researchers from McClintock’s time. In 1941,
McClintock demonstrated the phenomenon of
‘chromosome healing,’ where the ends of the
chromosomes behaved differently from ends created by
chromosomal breakage. When chromosomes break,
the free ends are known as double-strand breaks
(DSBs), which are repaired by a mechanism known as
non-homologous recombination (NHEJ) (Blackburn,
2001). The major molecular players of the NHEJ
pathway are the Ku heterodimer, Sir family of proteins
and the Mre11p-Rad50-Xrs2 complex (Bertuch and
Lundblad, 1998). Being the ends of the chromosomes,
telomeres often become uncapped during replication
and are structurally the same as DSBs (Blackburn,
2001). However, they do not fuse by the repair
mechanisms activated by NHEJ, since most cells
posses an unknown molecular machinery that prevent
telomeres from being identified as DSBs (Blackburn,
2001).
Initially, scientists thought of the existence of
a special mechanism that inactivates NHEJ machinery
on  telomeres.  Paradoxically,  the NHEJ  protein  Ku  is
     TTGGGGTTGGGGTTGGGG
TERT
TER
TTGGG
G
AACCCC
89
Figure 2. Telomere t-Loop-D-Loop (adapted from Grieder, 1999)
The figure shows the current model for the looping end of telomeres (Grieder, 1999). The model proposes that both the t-loop and D-loop
provide binding sites for several telomere-binding proteins (Grieder, 1999). Studies have shown that the stability of the D-loop depends on
the binding of TRF2.
also found to be a telomere binding protein (Haber,
1999) that is essential for nuclear organization of
telomeres (Laroche et. al., 1998), telomere length
maintenance (Gasser and Susan, 2000) and most
importantly for telomere protection from DNA
degradation (Baumann, 2000), fusions (Hsu et. al.,
2000) .  DNA cross- l ink ing assays and
immunofluroscence have demonstrated that Ku can
bind to telomere heterochromatin and to telomere
repeats (Hsu, 1999). When there is a DSB, Ku gets
delocalized from telomeres and activates the NHEJ
repair machinery (Gasser and Susan, 2000).
To make matters more complicated, similar to
Ku mutations, mutations in other NHEJ proteins
including Mre11p (Gasser and Susan, 2000) and DNA-
Pkcs (Gilley et. al., 2001) can also result in telomere
length impairment. This suggests that the DNA repair
machinery for DSBs and telomere maintenance
overlaps at several stages. Studies have also shown
that this enigmatic sharing of the DSB repair and
telomere maintenance is conserved from yeasts to
humans (Gasser and Susan, 2000). Nevertheless, no
one knows why the same molecular machinery repairs
telomeres and DSBs.
Many of the insights to the puzzle associated
with the overlap in the molecular mechanisms that
repair DSBs and maintain telomere length came from
the genetic experiments on yeast (Gasser, 2000). They
showed that the Ku heterodimer, Sir family of proteins
and the Mre11p-Rad50-Xrs2 complex that are
necessary for DSB and telomere maintenance are
regulated by the S-phase checkpoint proteins Tel1p
(yeast) or ATM (humans) (Craven et. al., 2002). This
discovery quickly provided a hypothetical solution to the
“DSB-Telomere-NHEJ” dilemma. The study suggested
that it is advantageous for the cell to have the same
machinery acting differently for both DSBs and
telomere dysfunction and therefore maintaining
chromosome stability, since, both events takes place
during or after DNA replication (Gasser and Susan,
2000).
The other major question in the field of
telomeres and DNA repair is the ways and means by
which the cell differentiates open-ended telomeres from
DSBs. Answers to this question also came from the
genetic studies on yeast have that led to the discovery
of two NHEJ proteins Taz1 (Ferreira et. al., 2001) and
NEJ1 (Liti et. al., 2003). Taz1 is a telomere binding
protein, whereas NEJ1 works with NHEJ ligases LIF1
and DNL4 (Liti et. al., 2003). Both interact with
telomeres and prevent them from being treated as
DSBs (Liti et. al., 2003). Although, extensive research is
being done in this field, to this day, the detailed
molecular and cellular processes underlying the DSB-
telomere dilemma or McClintock’s ‘chromosome
healing’ phenomenon is still a mystery.
Telomeres and Cell Cycle
In addition to the protective function, telomeres have
recently been found to play an important role in
meiosis. The potential link between telomeres and cell
cycle was first demonstrated by Chikashige et. al.,
(1994), who showed the clustering of telomeres during
prophase in S. cerevisiae. Further investigation of this
link demonstrated that alteration of telomere sequences
(Kirk et. al, 1997) or deletion of telomere associated
meiotic proteins like NDJ1 (Conrad et. al., 1997) or
Tam1 (Chua and Roeder, 1997) can result in abnormal
phenotype and growth patterns. Within the last seven
years, several other links between telomeres and
meiosis had been characterized such as the nucleolus-
associated clustering of telomeres before the formation
of synapses (Armstrong et. al., 2001) and the
requirement of functional telomeres for successful
chromosomal alignments (Funabiki et. al., 1993) and for
the integrity of spindles (Liu et. al., 2002)
Current Status of Telomere Biology and Our Lab’s
Goal
Within the last two decades, telomeres have thus
emerged as one of the most well studied fields of cell
and molecular biology. The t-loop and its structural
modifications on a timely basis for telomere
maintenance has been one of the major focuses of
research for the last five years (Evans et. al., 1999).
The complexity of telomerase structure, its regulation
and its associate components other than hTERT and
TER are also being investigated extensively (Evans et.
al., 1999). Along with research on telomerase mediated
telomere maintenance, scientists are also investigating
ALTs in yeasts and Drosophila (Evans et. al., 1999).
Initial studies on telomeres were based completely on
D-Loop
t-Loop
TRF2
DNA Binging
Proteins
90
single celled eukaryotes like T. thermophila. However,
the last decade has also witnessed an expansion by
including worms (C. elegans) and plants (Arabidopsis
thaliana) (Evans et. al., 1999). And as previously
mentioned, the connection of DNA repair pathways, cell
cycle progression and telomeres is also a growing area
of extensive research (Gasser et. al., 2000).
Our lab’s goal is to study the DNA component
of telomeres in T. thermophila. Most recent studies in
the lab have been focused on telomeres and cell cycle.
A common way to approach this is by altering the
telomere sequence using a telomerase with a mutated
RNA template sequence that can create sequence
specific mutations at the telomeric termini (Yu et. al.,
1990). The different T. thermophila mutants created in
our lab are 43A, 43AA & 44+AA and are so called
because of the specific telomeric sequence alterations
(Petcherskaia et. al, 2003). Previous studies by Kirk et.
al., (1997) on these mutants showed an arrest at
anaphase with absence of chromosome segregation.
We have further characterized the cell’s response to the
mutation and have investigated the molecular basis for
the defect. Examination of whether the cell cycle
continues despite the block in anaphase demonstrated
a dramatic increase in the proportion of micronuclei with
condensed chromatin, as well as an increase in the
proportion of cells with an intact mitotic spindle
apparatus (Christ, 2002). Further investigation of the
43AA mutant by southern blot analysis revealed that
telomere sequence mutations have also resulted in
extensive degradation of the micronuclear telomeric
DNA (unpublished).   
My Senior Thesis Project
The purpose of my study was to further extend the
investigation of the molecular basis of anaphase arrest
we observed in our telomere mutants. Although, we
have demonstrated extensive micronuclear telomere
degradation, we do not know whether the degraded
DNA is treated as DSBs. I predicted that the mutations
we induced in the telomeric DNA inhibited the binding
of the terminal telomere binding proteins thereby
destabilizing the t-loop-D-loop cap structure of telomeric
ends. Therefore, the exposed telomere would be
subject to the activity of exonucleases resulting in
extensive DNA degradation, as we have observed.
However, we are unaware of the extent, to which the
DNA has been degraded and we predict the existence
of three types of degraded chromosomes (Fig. 3).
Several studies have shown that shortened telomeres
(McEachern and Iyer, 2001) and sequence specific
telomeric mutations (McEachern et. al., 2000) can
result in telomere fusions. The formation of fusions
might occur because degraded telomere is no different
from DSBs and will, therefore be modified by the NHEJ
machinery leading to the fusion of chromosomes.
Therefore, I hypothesize that in our T. thermophila
telomere mutants, the extensive micronuclear DNA
degradation resulted in the formation of telomeric
fusions. Based on previous studies in the lab
(unpublished), I have excluded existence of the fusions
of non-degraded telomeres (Fig. 3) and hypothesize the
existence of three types of fusions (Fig. 3).
In order to test our hypothesis of telomere
fusions, we investigated the possibilities of several
candidate techniques used in other studies to detect
chromosomal fusions, such as pulse field gel
electrophoresis (Liti, 2003), polymerase chain reaction
(PCR) (Hackett et. al., 2001; Chan et. al., 2003), and
fluorescent in situ hybridization (FISH) (Espejel et. al.,
2002). However, pulse field gel electrophoresis and
FISH assay cannot be applied because they are
incapable of specifying telomeric fusions. In addition,
our lab lacks the technical facilities to conduct pulse
field gel electrophoresis, and FISH antibodies specific
to the T. thermophila have not been developed.
Therefore, we developed a PCR assay that can detect
telomeric fusions. Primers were designed from the
sequences just adjacent to the telomere of T.
thermophila called telomere-associated sequences
(TAS) (Fig. 3), which were cloned by Kirk et. al., (1995).
We also designed a positive control to ensure that our
assay could overcome the typical difficulties
encountered in amplifying long GC-rich PCR products.
PCR on the positive control demonstrated the ability of
our assay in detecting telomeric fusions up to 841 bp.
Among the different types of fusions listed in Fig. 3, we
are capable of detecting Types II and III, since our
primers are designed from TAS sequences. Although,
preliminary assays of the mutant DNA did not amplify
any fusion products, reamplification of the products
from PCR on digested DNA yielded potential fusion
bands. However, sequencing of these bands showed
them to be non-telomeric sequences.
Results
Creation of Artificial Telomere Fusions
To investigate the existence of telomeric fusions, I used
PCR with primers designed from TAS sequences.
Unfortunately, telomeres are notoriously difficult to
amplify by PCR because a) the high GC content of
telomeres can prevent the double stranded template of
the PCR from being denatured completely thereby
preventing the efficient binding of the primers and
enzymes and b) telomeres can inhibit PCR by the
formation of secondary structures. Therefore, to test the
potential of our PCR assay in detecting telomere
fusions, we developed a positive control by creating
artificial fusions and testing our primers on it. To
accomplish this, we used the T. thermophila TAS
sequences cloned by Kirk et. al., (1995). We cut out the
TAS sequences with telomeric tracts by restriction
digest with Sac I and EcoR V and were ligated to create
artificial fusions. The TAS sequences I selected were
called TAS A & TAS C, with sizes 296 bp and 511 bp,
respectively (Fig. 4). TAS A has 9 G4T3 and 23 G4T2
repeats, and TAS C has 37 G4T3 and 26 G4T2 repeats
(Fig. 4). The expected sizes of the different fusions of
TAS C & TAS A were 606 bp, 841 bp, and 1056 bp for
the artificial telomeric fusions types: a) TAS A & TAS A,
b) TAS C & TAS C, and TAS C & TAS A, respectively
(Fig. 4).
The next goal of the project was to test the
artificial fusions with the primers we designed from the
TAS sequences. We conducted PCR on the artificial
fusions using the respective primers and the products
were run on a 1.5% agarose gel. The gel (Lane 1, Fig.
5) shows two bands of expected sizes for the artificial
fusions A & A11 (606bp) and C & A (841bp). However,
we were unable to amplify the C & C fusion band. This
suggests the existence of a potential size barrier for the
PCR assay. We predict this to be due to the longer
stretches of the telomere tracts of TAS C & C artificial
fusion, when compared to the other two types of
artificial fusions (Fig. 4), thereby making the PCR
vulnerable to all the issues that is related to the
amplification of GC-rich sequences.
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Telomeric Tract: ~2.7 kb
G4T3 G4T2TAS
a) Wild Type
Type I
Type II
Type IVType III
b) Mutant
c) My Hypothesis
Fusion
Type II
Type III
Type IV
Figure 3. Different types of fusions that can potentially exist. The figure of T. thermophila was adapted from Asai et. al., (2000)
The wild type micronuclear DNA (a) consists of a telomeric tract of size ~2.7 kb with the internal and external telomeric tracts G4T3 and
G4T2, respectively. In our T. thermophila telomere mutants, previous studies have suggested the types of degraded telomeres potentially
existing (b), based on which I hypothesized the existence of three types of chromosomal fusions (c). Among these (c), we are searching for
Type II and Type III, since our primers are designed from the TAS sequence.
T. thermophila
T. thermophila
Macronucleus
Micronucleus
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Figure 4. Types of Artificial Telomere Fusions
TAS sequences with telomeric tracts were cut out by restriction digest with TAS A and TAS C having a size of 296 bp and 511 bp,
respectively.  They were ligated to create three types of fusions : a) TAS A & A Fusion (606 bp), b) TAS A & C Fusion (841 bp), and c) TAS
C & C Fusion (1056 bp). The sizes of the images are scaled to 10 mm for 1 bp.
Optimization of the PCR Assay
To determine the minimum amount of the artificial
fusions and optimal annealing temperature that are
required for our PCR assay, different dilutions (1:10,
1:100 & 1:1000) of the artificial fusions were tested
using TAS C and TAS A primers (Materials & Methods)
at temperatures ranging between 56°C and 58°C (Fig.
5). The PCR products were run on a 1.5% agarose gel
(Fig. 5) and it shows the ability of the PCR in amplifying
telomeric fusions: a) A& A (606 bp), b) C & A (841 bp)
at annealing temperature 56°C from all the three
dilutions (Fig. 5; Lanes 1, 2, & 3). But at 58°C, the
efficiency of the PCR to detect fusions from the 1:1000
dilution dramatically decreased (Fig. 5; Lanes 5, 6, and
7). This optimization experiment indicated that our
assay was most efficient, with minimal non-specific
binding at an annealing temperature of 56°C and with a
template concentration of 1:10 or1: 100 of the artificial
fusions (Fig. 5; Lanes 1 & 2).
Although, my assay was successful in
detecting two artificial fusions with expected sizes (Fig.
5), the PCR also amplified several bands of unexpected
sizes. The prevalence of these bands was less
dramatic with decrease in the concentration of the
artificial fusion (Lanes 1, 2, 3, 5, 6, & 7; Fig. 5),
suggesting that they were due to the non-specific
binding of the primers. However, the existence of non-
specific products questions the specificity of the PCR
products. Therefore, we conducted a nested PCR using
primers PRX TAS C and PRX TAS A. These primers
were designed 3’ to the primers TAS A and TAS C. As
expected, the nested PCR demonstrated a decrease  in
Figure 5. Thermal & Volumetric Optimization of the PCR
assay
PCR was conducted on the different dilutions of the A & C
artificial fusions at annealing temperatures 56.00C & 58.00C
and was run on an agarose gel. The content of each lane is
labeled with the respective annealing temperature and template
dilution used for each PCR. The gel shows the A & A and A & C
fusions with expected sizes 841 bp and 606 bp (blue arrows),
but lacks the C & C fusion band of size 1056 bp.
a) TAS A & A Fusion Length = 606 bp
b) TAS C & A Fusion Length = 841 bp
c) TAS C & C Fusion Length = 1056 bp
Scale: 1 bp = 10.0 mm
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Figure 6. Nested PCR
PCR was conducted on the 1:10 dilution of the C & A ligates at
56.00C. One µl of the product was then used for the nested
PCR. Both products were run on an agarose gel. The content of
each lane is as follows, Lane 1: PCR on 1:10 dil. of C & A ligate
at 56.00C, Lane 2: Nested PCR, Lane 3: 100 bp PCR Ladder.
the sizes of the PCR products we predicted to be
artificial(Fig. 6; Lanes 1 & 2). The C & A (841bp) and A
& A fusion products (606bp) show a decrease of 94 bp
and 140 bp to give a 735 bp and a 546 bp fragment,
respectively (Fig. 6; Lanes 1 & 2). In addition, the non-
specific bands produced by the assay were not
reproducible and those that did reappear did not drop
down (Fig. 6), thereby further confirming the specificity
of our assay.
43AA genomic DNA can inhibit the efficiency of our
PCR assay
My assay succeeded in detecting artificial telomere
fusions. However, I anticipated that when repeated in
the presence of genomic DNA, the PCR efficiency
would decrease. This is because genomic DNA can act
as a competitor by providing multiple sites for primer
binding or can inhibit the reaction due to its complex
structure and sequence complexity. Therefore, it was
necessary to test the PCR efficiency in the presence of
genomic DNA. I aimed to mimic the in vivo situation,
where my assay needs to amplify the fusions from a
large amount of genomic DNA. Ultimately, my goal was
to estimate the minimum number of fusions the assay
requires to amplify it from the maximum amount of the
genomic DNA. I addressed this issue in two steps.
Firstly, I was interested in examining the
minimal amount of 43AA genomic DNA that could
compete or inhibit the PCR reaction. Therefore, PCR
was conducted on 1:10 dilution of the artificial fusion
mixed with different dilutions (Materials & Methods) of
the 43AA genomic DNA. The products were run on a
1.5% agarose gel (Fig. 7). The absence of any bands in
Lane 1 (Fig. 7) demonstrated that either the genomic
DNA itself or an unknown factor present with the
genomic DNA inhibited PCR drastically. However, as
we decreased the amount of genomic DNA in serial
dilutions, the artificial fusion bands of expected sizes
(841 bp & 606 bp) were amplified (Lanes 2 through 7;
Fig. 7). Between the different dilutions (Lanes 2 through
7), the PCR efficiency was similar, since the intensity of
the fusion bands (841 bp & 606bp) was invariant
(Lanes 2 through 7; Fig. 7). This suggested that the
competitive/inhibitory roles of either the genomic DNA
or the unknown factor associated with the genomic
DNA was decreased by dilution. The experiment also
shows that the maximum amount of genomic DNA that
potentially may not affect PCR efficiency and still can
be used as a PCR template is a 1:10 dilution, although
smaller dilutions needs to be considered.
Figure 7. Diluted 43AA Genomic DNA did not affect PCR
efficiency
PCR was conducted on the different dilutions of the 43AA
genomic DNA along with C & A ligate at 56.00C and was run on
an agarose gel. Lane 9 conssits of 10 µl of the 100 bp PCR
Ladder. Lanes 2 to 7 consist of products from PCR on 1:10
dilution of the artificial fusion mixed with: non-diluted genomic
DNA (Lane1), 1:10 (Lane 2) , 1:100 (Lane 3), 1:1000 (Lane 4),
1:10,000 (Lane 5), 1:100,000 (Lane 6), and 1:1,000,000 (Lane
7) dilutions of the 43AA genomic DNA.
Secondly, I estimated the minimum amount of artificial
fusions that the assay required as templates in the
presence of 1:10 dilution of genomic DNA. PCR was
conducted on non-diluted artificial fusion and on
different dilutions of the artificial fusions in the presence
of 1:10 dilution of 43AA genomic DNA. The gel for the
PCR products (Fig. 8) shows successful amplification of
fusions (841 bp & 606 bp) from non-diluted and 1:10
dilution of the artificial fusion in the presence of
genomic DNA. However, the PCR was unable to
amplify any fusions from dilutions above 1:10 (Fig. 8;
Lanes 4 through 7). Thus, I demonstrated that my
assay had a concentration limit to successfully amplify
telomeric fusions. The experiment shows that 1:10
dilution of the artificial fusion was the minimum amount
of the artificial fusion that could give rise to a fusion
product by PCR in the presence of 1:10 dilution of
43AA genomic DNA (Fig. 8).
Considering the results of the two
experiments (Fig. 7 & Fig. 8), I anticipated the
molecular problems caused by the inhibitory roles of
genomic DNA and the minimum number of fusions that
are required for our assay to amplify. The first
experiment (Fig. 7) suggests that any dilutions less than
1:10  of genomic DNA can  inhibit the PCR. The second
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Figure 8. 43AA Genomic DNA did not inhibit PCR on 1:10
dilution of artificial fusions
PCR was conducted on the different dilutions of C & A ligate
along with 1:10 dilution of 43AA genomic DNA at 56.00C and
was run on an agarose gel. Lane1 consisted of 100bp PCR
Ladder. Lanes 2 to 7 consist of products from PCR on 1:10
dilution of the 43AA genomic DNA mixed with: non-diluted
(Lane 2), 1:10 (Lane 3) , 1:100 (Lane 4), 1:1000 (Lane 5),
1:10,000 (Lane 6), and 1:100,000 (Lane 7) dilutions of the
artificial fusion.
experiment (Fig. 8) shows that any dilution above 1:10
might by pass the minimum number of template fusions
required for the PCR to amplify. Based on these two
results, I concluded that to yield the maximum efficiency
of the PCR, I should use 1:10 dilution of the 43AA
genomic DNA to investigate the existence of telomeric
fusions
PCR on 43AA DNA does not give any PCR Products
Our PCR assay was able to detect fusions up to 841 bp
long. Therefore, I anticipated the possibility of detecting
fusions from the 43AA genomic DNA within this size
range. For PCR, I used a 1:10 dilution of 43AA genomic
DNA, since, non-diluted genomic DNA demonstrated to
be inhibitory to PCR. All the primers combinations
possible from the different primers (TAS A, TAS B,
TASC, TAS D, TAS E, and TAS F) were used for the
PCR. However, we did not see any products (data not
shown). Similar kinds of results were seen when PCR
was conducted on 1:1000 dilution of 43AA genomic
DNA (data not shown).
PCR on digested 43AA DNA does not give any PCR
Products
The absence of fusion products from 43AA genomic
DNA by PCR suggested several possibilities, such as:
a) micronuclear telomeric fusions may not exist, b) the
size of the telomeric fusions existing are larger than the
amplification potential of our PCR assay, and c) the
genomic DNA itself is inhibiting the efficiency of the
PCR due to its sheer size. To resolve last issue, I
decided to digest the 433AA genomic DNA with the
enzyme Mse I. We anticipated that the digestion would
reduce the secondary structure formation of the
genomic DNA, if it were the causative agent for
reducing PCR efficiency, thereby increasing its
availability for PCR. Another issue that concerned the
assay was the low GC content and short lengths of the
primers we used (Table 1). Therefore, we designed
new primers (Last 3 rows; Table 1) with longer size and
high GC content that could anneal to the template for
longer periods thereby increasing the efficiency of PCR.
PCR was then conducted on the digested
43AA genomic DNA using the new primers. The
positive control consisted of the artificial fusion with
digested non-diluted 43AA genomic DNA. The PCR did
not detect any fusion products (Fig. 9; Lane 3 through
8), as we did not see any bands. However, PCR on the
artificial fusions in the presence of non-diluted 43AA
DNA did show the expected band (Fig. 9; Lane 1). This
was an encouraging result. Because, previous parts of
this study had shown the inability of the assay to detect
artificial fusions in the presence of non-diluted genomic
DNA (Fig. 7, Lane 2). This suggests that the digestion
of the DNA and the new primers had indeed increased
the efficiency of the PCR. The absence of any telomeric
fusion bands from mutant genomic DNA might be
because of their low numbers.
Figure 9. PCR on digested 43AA genomic DNA does not
give products
PCR was conducted on Mse I digested 43AA genomic DNA
and was run on an agarose gel. Newly designed primers with
high GC content and longer size were used (Materials &
Methods). Annealing Temperature: 65.00C. Lanes 1 & 2
consists of PCR on 1:10 dilution of artificial fusion with primers
NEW TAS A &  NEW TAS C and 100 bp PCR Ladder,
respectively.  Lane 3  to 9 consist products from PCR on Mse I
digested 43AA genomic DNA with the “NEW TAS” primers:
Lane 3: A alone, Lane 4: A & C, Lane 5: A & E, Lane 6: C
alone, Lane 7: C & E, Lane 8: E alone.
Detection of Potential Fusions After the
Reamplification of the PCR Products
The initial set of experiments had demonstrated that my
PCR assay requires a certain number of telomeric
fusion events as the minimum number to amplify them.
Therefore, a potential reason for the absence of any
products by PCR on 43AA genomic DNA (Fig. 9) might
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have been the low number of fusion events. To resolve
this problem, the PCR products from 43AA genomic
DNA were reamplified by a second cycle of PCR. I
predicted that the additional recycling should yield the
potential fusion bands that are amplified to the PCR’s
minimum template level by the initial 30 cycles.
However, I also anticipated the amplification of a
number of non-specific products due to non-specific
binding of the primers during reamplification. Therefore,
the experiment was repeated on wild type (WT)
genomic DNA, which according to our hypothesis does
not posses any telomeric fusions.
Surprisingly, PCR yielded products from both
WT (Fig. 10; Bottom row) and 43AA genomic DNA (Fig.
10; Top row) templates. Lanes 4, 7, and, 10 in each row
(Fig. 10) are followed by the corresponding
reamplification products. The reamplification of the
positive control (Fig. 10; Lane 4; Row 1) shows several
non-specific bands. Overall, each of the lanes
containing the reamplification products demonstrates
extensive smearing suggesting the amplification of
several non-specific products. Interestingly, none of the
products from WT DNA template is of the same size as
the ones from 43AA genomic DNA suggesting that
either telomeric fusions exist in low number in both WT
and 43AA genomic DNA or that the PCR products are
due to the non-specific binding of the primers at
different sites of the template DNA.
Figure 10. Reamplification of PCR on digested 43AA
genomic DNA give products
One µl of the product from the PCR on 1:10 dil. of digested
43AA genomic DNA was used for reamplification by another
cycle of PCR. The positive control (Lane 3) was also
reamplified (Lane 4). Lanes 4, 7, and 10 consist of products
from PCR on Mse I digested 43AA genomic DNA with primers:
NEW TAS A, NEW TAS C, and NEW TAS E, respectively.
Lanes 5, 8, and 11 are the products of the remplification PCR
conducted on the contents in Lanes 4, 8, and 11, respectively.
The contents in the bottom row are similar to the top row except
that the template used was wild type DNA and the positive
control was not conducted again.
In order to confirm whether the bands were due to
telomeric fusions, we conducted southern blot analysis
on the gel from Fig. 10 (Fig. 11) using a telomeric probe
specific to micronuclear telomere sequence G4T3 (Fig.
4). The southern blot exhibited strong telomeric (G4T3)
signals at those sections of the gel (Fig. 10; Lanes 6, 9,
& 12) that corresponds to the remplification products
from both WT (Fig. 11; Bottom Row) and 43AA
genomic DNA (Fig. 11; Top Row). A closer analysis
shows that the intensity of the signals increases at
those points in the Southern Blot (Fig. 11) where a
potential fusion band was observed in Fig. 10. The
strong presence of G4T3 signals further suggests that
the PCR products from both WT and 43AA genomic
DNA might be fusions.
Figure 11. Southern Blot Analysis of the Reamplification
Products
Southern Blot was conducted on the gel from Fig. 10 using a
G4T3 probe. The annealing and wash temperatures were
55.00C and 60.00C, respectively. The presence of signals in
reamplifications lanes in both Row 1 (43AA DNA) and Row 2
(Wild type) suggests either the presence of too much
background or the presence of fusions in both type of DNA.
For further verification, it was decided to sequence the
PCR products. The experiment was repeated. In both
the top and the bottom rows (Fig. 12), lanes 8, 11, and
14 consist of the reamplified PCR products. Compared
to Fig. 10, we observed extra bands for each of the
remplification reaction. I decided to clone those PCR
products that do not repeat themselves in the WT row
(Bottom; Fig. 12). I also avoided products less 200 bp
long, since they could either be formed due to primer
dimers or due to the non-specific binding of the primers.
Arrows with specific colors indicate the PCR products
selected for cloning (Fig. 12). The names and sizes of
these products are summarized in Table 3, with respect
to their colored arrow. Figure 13 shows successful
cloning and sequencing of the fusion products Mut. A1,
Mut. C1, and, WT. A1 (Figure 13). The respective
primers used are matched to the cloned sequences
(Figure 13). And lastly, sequencing of plasmids to which
the PCR products Mut. A2, Mut. E1, WT. A2, and WT.
C1 were cloned showed the absence of any inserts
(Data not shown). The sequencing results suggests
none of the PCR products we sequenced were
telomeric fusions, thereby demonstrating them to be
formed by the non-specific binding of the primers during
the reamplification cycle.
Discussion
My study demonstrates that the PCR assay I developed
can amplify telomere fusions up to 841 bp. The
absence of any fusion bands from PCR on mutant
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genomic DNA suggests that telomere fusions up to 841
bp  may  not exist in the telomere mutants  we  created.
Table 3. The names and sizes of potential fusion bands from Figure 12
Figure 12. Reamplification of PCR on digested 43AA
genomic DNA
The contents of the gel (above) is similar to Fig. 10. Potential
fusion bands that are present in either rows were selected for
cloning. The names and sizes of these bands are matched to
the respective arrow and are summarized in the Table 2
(below).
If they do exist, I predict the number of such fusion
events to be below the amplification limit of our assay.
The possibilities of telomeric fusions larger than 841 bp
cannot also be ruled out, since, our assay has a size
barrier of ~841 bp.
Telomeres: the Nemesis of PCR and the
Significance of a Positive Control
PCR is one of the most significant and useful
techniques of biotechnology. It is a fast and efficient
method to amplify known DNA sequences. However, in
my study, I demonstrated that telomeric fusions are
DNA templates that are extremely difficult to be
detected by PCR. The PCR assay demonstrated its
ability to detect telomere fusions with sizes 606 bp &
841 bp, but it failed to amplify the TAS C & C fusion,
which has a size of 1056 bp. From a molecular
perspective, studies have shown that the efficiency of
PCR is affected by several parameters such as
template complexity, and template sequence, primer
sequence and stability, polymerase type, buffer type,
(Innis, 1999). Among these, one or more of factors may
provide insights to the inherent size barrier of our assay
as summarized below.
GC-Content of the template: The high GC content of
telomeres might be one of the primary reasons for this.
In a double -stranded DNA   molecule, G   and C are
bound  by   three  hydrogen  bonds  and  therefore,  the
thermal energy required to denature GC rich strands for
PCR are much higher than conventional DNA
sequences (Moreau et. al., 1994). The issue of GC
content worsens, when telomeric sequences need to
amplified by PCR, since, it consists of tandem GC
repeats (Pherson, 2000). To resolve this issue, most
studies recommend elevated denaturation temperature
of 980C from conventional conditions of 950C to ensure
efficient denaturation of long stretches of telomeres
(Pherson, 2000). Although, I used 980C as the
denaturation temperature, during the primer binding
and extension phases of PCR, the reaction temperature
lowers to ~600C. This might have affected the PCR
efficiency due to potential of single stranded telomeric
sequences to form secondary structures such as
hairpins as demonstrated by Henderson et. al., (1987)
and Gualberto et. al., (1992) that can lead to premature
prime binding and the inhibition of the DNA polymerase
from synthesizing new DNA.
Size and GC Content of the Primer: I also propose that
the primers I designed (Table 1) might have contributed
to the inefficiency of the PCR assay in amplifying the
1056 bp artificial fusion. If the size of the template to be
amplified is long, the respective primers must stay on
its binding site for a longer time period, which is chiefly
determined by high GC content and large size of the
primers (Beasley et. al., 1999). However, the primers I
designed were short (20-22 bp) and low in GC content
(25-60%) that may have resulted in premature primer
binding.
Primers and Secondary Structures: In addition to GC
content and size, studies have shown that the ability of
the primers to form secondary structures, like self-
duplexes, can also lead to premature primer-template
binding (Breslauer et. al., 1986 & Kolmodin and
Williams, 1997). Table 1 shows that several of the
primers had secondary structure formation properties
indicating its potential along with the other factors in
inhibiting the PCR. Although, the primers TAS C and
TAS A were able to amplify the telomeric fusions of 606
bp and 841 bp, either of them could also form self-
duplexes. Therefore, it is possible that their primer
binding ability is competing with the secondary structure
formation, in which self-duplex formation might be the
dominating while amplifying the 1056 bp telomeric
fusion. Consequently, at a fixed time period, the
number of primers available for efficient primer-
template binding would be lower resulting in the
amplification of less number of the 1056 bp telomeric
fusions.
Type
Name Mu t.
A1
Mu t.
A2
Mu t.
C1
Mu t.
E 1
W T .
A1
W T .
A2
W T .
C1
~ Size (bp) 369 320 263 280 334 250 360
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Tp and Tm of Primers: The other factor that may have
played a role in reducing the efficiency of the PCR is
the drastic difference Tp and Tm. Several studies have
shown  that  if Tm  >  3
0C  than Tp, the primer with higher
 
Sequence of Mut.A1
Sequence of Mut.C1
Sequence of WT.A1
5’
CGTTCCGAACAACCTCAAAGTTGTGAGGAACG CAGCCAACAGCCAAAAGG
TTCTGAGGAACGCAGCCAACAGCCAAAAGGTCCTGAGGAACGCAGCCAACAG
CCAAAAGGTTCTGAAGAACGCAGCCAACAACCAAAAGGTTCTGAGGAAGGCA
GCCAGCAGCCCAAAGGTTCTGAGGAACGCAGTCAACAGCCAAAAGGTTCTGA
GGAACGTAGCCAACAGCCAAAAGGTTCTGAGGAAGGCAGCCAACAGTCAAA
AGGTTCTGAGGAACGCAGCCAACAGCCAAAGGGTTCTGAGAAACGCGTTCCT
CACAACTTTGAGGTTGTTCGGAACGGCG CGTTCCTCACAACTTTGAGGTTG
TTCGGAACG 
3’
5’
GTTCCGAACAGCCACTAGGTTGTGAGGAACG TAAAAAATCTAAAATAGAGC
GTAGCAAACAAGCAAGCAAGCAAGTCATCAATAAAATCAAACCAATCTATATA
GACAAAGGAAGAGAGAAAAAAAAATAATGAAAAAAAGTTTGGAAAACAAAG
GAATGATAAAGAAAGAAACCAAATAATTTGTAATTTTGAATTGATCTATGATG
TATTTCATAAGAGAATGAAAATTA CGTTCCTCACAACCTAGTGGCTGTTCGG
AAC
3’
5’
CGTTCCGAACAACCTCAAAGTTGTGAGGAACG CGTTTCTCAGAACCCTTTGG
CTGTTGGCTGCGTTCCTCAGAACCTTTTGACTGTTGGCTGCCTTCCTCAGAACCT
TTTGACTGTTGGCTACGTTCCTCAGAACCTTTTGGCTGTTGGCTGCGTTCCTCAG
AACCTTTTGGTTGCTGGCTGCCTTCCTCTGAACCTTTTGGCTGTTGGCTGCGTTC
CTCAGAACCTTTTGGCAGTTGGCTGCGTTCCTCAGAACCTTTTGGCTGTTGGCT
GCGTTCCTCAGAACCTTTTGGCTGTTGGCTG CGTTCCTCACAACTTTGAGGTT
GTTCGGAACG
3’
Figure 13. Sequences of Reamplified PCR Products
The PCR products selected from Fig. 12 were cloned and sequenced and they showed to be non-telomeric. The sequences of Mut. A1,
Mut. C1, and WT.A1 are matched to the primers used (bolded & underlined), while the sequences of Mut. A2, Mut. E1, WT. A2, and WT.
C1 showed no inserts in their respective plasmids.
Tm will anneal to secondary priming sites at the lower
temperature optimal for annealing of the second primer
(Cheng and Kolmodin, 1997). The difference between
Tp and Tm were more than 3
0C for all the primers I
designed suggesting that the secondary binding of the
primers might have competed with the primary binding
leading to a decrease in the PCR amplification. The
presence of the non-specific products further confirms
the secondary binding properties of the primers. All
these factors may have negatively affected the
efficiency of the PCR in amplifying the 1056 bp artificial
fusion. Therefore, in the later parts of the study (Fig. 5-
Fig. 9), longer primers with high GC content were used.
Enzyme Fidelity: Although, the enzyme (ThermAce) is
shown to be a high fidelity enzyme (Barnes, 1992) that
is able to amplify GC-rich templates of size (Barnes,
1994), the study has not demonstrated the enzyme’s
ability in amplifying large telomeric tracts. In addition,
the enzyme have an inherent limit of ~850 bp for
amplifying telomeric tracts, which also might have
affected the efficiency of our PCR assay. Studies have
also shown that the efficiency of the enzyme can vary
with changes in the concentrations of MgCl2 (Innis et.
al., 1990 & Erlich et. al., 1989) and other buffers such
as EDTA in the PCR reaction mixture (Zangenberg et.
al., 1999). The buffers and the different salts present in
reaction mixture determine the ionic strength and
buffering capacity required for the fidelity of the enzyme
(Zangenberg et. al., 1999). However, we have not
examined the effects of changing the salt
concentrations of the buffer in product specificity.
Due to the afore-mentioned reasons, it was
very crucial to create artificial telomere fusions as
positive control upon which our PCR assay could be
tested. This is because, if the assay cannot
demonstrate its ability to amplify telomeric fusions from
the positive control, a negative result from the real
experiment on mutant genomic DNA cannot be used to
differentiate between the absence of fusions and the
limitations of the PCR assay.
Genomic DNA’s Inhibitory Properties against PCR
Our goal was to detect fusions from mutant genomic
DNA and our positive control was capable of amplifying
telomeric sequences up to 841 bp. Nevertheless, from
the view point of PCR, the reaction scenarios of using
the positive control and genomic DNA as templates are
drastically different. When using artificial fusions as
templates, the primers and the enzymes are faced with
only the DNA sequences ranging from 606 bp to 1056
bp or more created by multiple ligation reactions.
Conversely, the genomic DNA is the collection of the
entire genome of T. thermophila, which is in the order of
2x105 kb for the micronucleus (Yao et. al., 1974) and
9x106 kb for the macronucleus (Woodard et. al., 1972).
Consequently, there are several factors the PCR needs
to overcome to detect fusions from genomic DNA in
addition to those already mentioned (Cheng and
Kolmodin, 1997). Firstly, the complexity of genomic
DNA in the reaction can provide numerous non-specific
binding sites for the primers (Cheng and Kolmodin,
1997). And secondly, the tendency of genomic DNA to
undergo intra-molecular rearrangements, such as super
coiling (Alberts, 2002), formation of self-duplexes
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(Alberts, 2002) and formation of secondary structures
(Alberts, 2002) can lead to premature primer binding,
inaccessibility of the primers to their binding sites and
withdrawal of DNA polymerase (Cheng and Kolmodin,
1997). In addition to the problems faced by PCR with
genomic DNA, my assay also needs to overcome the
difficulties of amplifying telomeric sequences. Several
studies have demonstrated the difficulty in amplifying
telomeric sequences from genomic DNA (Hackett et.
al., 2001; Chan et. al., 2003).
Therefore, to create an ideal positive control,
it was crucial to test the efficiency of our assay in
detecting telomeric fusions in the presence of genomic
DNA. By doing so, I mimicked a “real” experiment,
where the PCR needs to amplify telomeric fusions from
genomic DNA. I conducted PCR on different mixtures of
the artificial fusion and the mutant genomic DNA that
varied in the amount of each reaction. The experiment
suggested to us the minimum amount of the artificial
fusion the PCR assay required to amplify it in the
presence of the maximum amount of the genomic DNA.
When the amount of genomic DNA was decreased by
serial dilutions, the assay succeeded in detecting
artificial telomeric fusions from its 1:10 dilution.
Furthermore, when the experiment was repeated with
different dilutions of the artificial fusion in the presence
of the genomic DNA, the assay was unable to detect
artificial fusions from dilutions above 1:10. These
results clearly demonstrate the inhibitory effects of the
genomic DNA.
When we did the “real” experiment on 43AA
genomic DNA with no addition of artificial fusions, we
did not see any products (data not shown). This might
be because one or more of the reasons that have been
discussed. Similar to our results, other studies (Moreau
et. al., 1994) have also shown reduction in the
efficiency of PCR on telomeric DNA due to its ability to
form secondary structures. Several studies have solved
the inhibitory roles of genomic DNA on PCR by
digesting it with an endonuclease (Hackett et. al., 2001;
Chan et. al., 2003). Theoretically, the concept works on
the premise that digestion of genomic DNA will reduce
the formation of secondary structures and increases the
accessibility of the primers to the binding sites. I
decided to conduct PCR on 43AA genomic DNA
digested with Mse I because: a) it can digest AT-rich
templates like that of T. thermophila and b) it does not
posses any restriction sites 5’ to the primers we had
designed thereby preventing the digestion of potential
fusions that could be detected by our assay. Along with
digested DNA, I also designed longer primers with
higher GC content as recommended by other studies
(Hackett, 2001; Chan, 2003). PCR on MseI digested
DNA with the new primers also did not yield any
products. However, the experiment shows that the
usage of digested DNA or the new primers or both had
increased the efficiency of the assay. Because PCR on
digested and non-diluted 43AA genomic DNA with the
new primers yielded the expected products, whereas
the same experiment with non-digested and non-diluted
43AA DNA with the old primers did not.
Frequency of Fusion Events in our T. thermophila
telomere mutants
Although usage of digested genomic DNA increased
the efficiency of the PCR, the assay did not detect any
fusion bands. One possible cause for this might have
been the absence of the optimal number of fusions in
mutants that the assay requires to amplify. In fact,
studies in S. cerevisiae (Chan et. al., 2003 and Liti et.
al., 2003) and Arabidoposis thaliana (Riha et. al., 2003)
have shown that the number of telomeric fusions events
that occur due to telomeric mutations are very small,
although mutated telomeres are highly recombinogenic
(McEachern and Iyer, 2001).  These studies have
suggested that in S. cerevisiae and A. thaliana, proteins
such as NEJ1 and Ku, respectively prevents NHEJ-
dependent telomere fusions. In my study, if telomere
fusions are created by the activation of NHEJ
machinery that was activated to repair our mutant’s
degraded telomeres, adjacent molecular pathways
using proteins with similar functions as NEJ1 might also
be in work to prevent NHEJ, resulting in low numbers of
fusions.
Therefore, we decided to reamplify our PCR
products. Reamplification of the PCR yielded products
from both 43AA genomic DNA. Surprisingly, the PCR
amplified products from wild type DNA yielded too.
Southern blot analysis of these bands showed strong
signals in those lanes containing the reamplification
products. This suggested to us either that telomeric
fusions might be present in both wild type and 43AA
genomic DNA in low number, or that what we observed
were artifacts of reamplification. However, cloning of
these bands showed them to be non-telomeric
sequences. From the perspective of PCR, the cloning
result was not surprising, since, studies have
demonstrated the formation of unwanted non-specific
products when the number of PCR cycles is increased
due to the non-specific primer binding (Innis et. al.,
1990 & Erlich et. al., 1989). The strong signals
observed in the Southern Blot might be due to the
presence of the non-specific binding of the telomeric
probe to the background DNA. Interestingly, such
signals were not seen in those lanes containing non-
reamplified PCR products, which suggest that the
reamplification has produced a large amount of artifacts
that provides non-specific binding sites to the telomeric
probe.
Summary & Future Research
In conclusion, I have created a PCR assay that can
amplify telomeric fusions. Nevertheless, due to the
several factors that have been discussed, the assay
also has a size limit of 841 bp. The absence of any
PCR products suggests that either telomeric fusion up
to 841 bp may not exist or their numbers are below the
amplification potential of the assay. Nevertheless, when
compared to other studies (Chan et. al., 2003), this
study demonstrates its potential in detecting telomeric
fusions by PCR that are much larger than the
conventional telomeric fusions detected by PCR, which
is between 100-150 bp (Chan et. al., 2003).
Our assay was unable to detect artificial
fusions above 841 bp. Therefore, further studies should
be conducted on the existence of larger telomeric
fusions and non-telomeric fusions. To further increase
the efficiency of the assay, varying the concentrations
of MgCl2 (Innis, 1990 & Erlich, 1989) of the PCR buffer
and the application of co-solvents such as dimethyl
sulfoxide (DMSO) (Winship, 1989), formamide (Sarkar,
1990) ,  g l yce ro l  (Landre ,  1995) ,  and
tetramethylammonium chloride (TEMAC) (Hung, 1990)
to melt secondary structures are options that could be
explored. Technique wise, pulse field gel
electrophoresis is a potential method that could be
applied to investigate the existence of chromosomal
fusions, although it cannot differentiate between
chromosomal and telomeric fusions.
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For future research, we are also interested in
exploring whether telomeric fusions exist in the
macronucleus. Previous studies in the lab have shown
that the sequence specific telomeric mutations had not
resulted in the macronuclear telomeric degradation
unlike the micronucleus. However, whether
macronuclear telomeric fusions exist or not in our
mutants remain unanswered. Conceptually, the same
assay could be applied for the investigation using
primers designed from the macronuclear TAS
sequences.
The study by Kirk et. al., (1997) have
demonstrated that sequence specific telomeric
mutations display an acute mitotic chromosome
segregation defect at anaphase, which eventually result
in cell death. Nevertheless, further research must be
conducted to explore whether the mutants are
undergoing apoptosis or some other kind of cell death
mechanism such as necrosis. In addition, the molecular
mechanisms activated by the mutations that caused the
cell death are also another area that needs to be
examined. Further characterization of the mitotic defect
observed by Kirk et. al., (1997) in our lab established
more evidence for the anaphase arrest (Christ, 2002)
and extensive micronuclear DNA degradation
(unpublished) by monitoring the progression of cell
cycle. In these mutants, we are also interested in the in
examining molecular indicators such as the over
expression of anaphase and checkpoint specific
proteins.
Experimental Procedures
Creation of Artificial Fusions
pUC19 plasmids containing T. thermopila TAS sequences with
telomeric tracts were cloned by Kirk et. al, (1995). Frozen
clones of TAS A and TAS C were thawed at room temperature
for a few seconds and inoculated into LB/Amp cultures (1.0%
Bacto-Tryptone, 0.5% Bacto-Yeast Extract, 1.0% Sodium
Chloride, 1% Ampicillin in sterile nano pure H2O). The pUC19
plasmids were isolated (Qiagen Plasmid Purification Kit;
Valencia, CA;) and digested with Sac I (New England BioLabs;
Beverly, MA), and EcoR V (New England BioLabs; Beverly,
MA) as recommended by Kirk et. al, (1995). The reaction recipe
consists of 62% sterile nano pure water, 10% NEB Buffer 2
(New England BioLabs; Beverly, MA), 10% BSA (New England
BioLabs; Beverly, MA), 10% pUC19 plasmids, 4% of Sac I and
EcoR V in a total reaction volume of 20 µl. The restriction
products were extracted (QlAquick Gel Extraction Kit by
Qiagen; Valencia, CA) from a 1.5% agarose gel and joined by
ligation to created artificial fusions. The ligation reaction
consisted of 1 µl of T4 DNA ligase (Invitrogen, Carlsbad, CA), 1
µl of the respective templates, 1 µl of ligation buffer, and 4 µl of
sterile nano pure water at 14°C for ~14hrs.
Polymerase Chain Reaction (PCR)
A PCR assay was designed to amplify telomeric fusions. In
order to denature the telomeric templates and any secondary
structures, the PCR assay we designed has a higher
denaturation temperature (98°C; Pherson, 2000) and longer
denaturation time (3 min), when compared to the conventional
denaturation temperature and time of 95°C and 1 minute. The
melting temperatures of the primers were 65.8°C and 67.26°C
and therefore the annealing temperature was maintained
between 56°C–58°C. The size of micronuclear telomeres is ~6.0
kb (Kirk et. al, 1995). To amplify such large fusion fragments of
size above 3.0 kb, the extension time of the PCR was
maintained at 7 minutes. And finally, a special enzyme called
ThermAce (Invitrogen; Carlsbad, CA) that can amplify GC-rich
templates and stable at higher denaturation temperatures and
longer extension times was used for the PCR. The amounts of
the buffers, primers, sterile nano pure water and template used
were adapted from the ThermAce Enzyme Kit. The PCR was
conducted in a MJ Research PTC-200 Peltier Thermal Cycler
with denaturation at 98°C for 3.0 minutes, annealing
temperature was maintained 10°C less than the primer melting
temperature) for 30 cycles, extension at 72°C for 7.0 minutes
and final extension at 72°C for 10.0minutes.
Design of Primers
The primers were designed from the T. thermophila TAS
sequences (Table 1). The 11 primers were labeled as TAS A,
TAS B, TAS C, TAS D, TAS E, and TAS F (Table 1). To
conduct nested PCR, sequences 3’ to the primers TAS A and
TAS C were used to develop PRX TAS A and PRX TAS C
(Table 1). The last three primers (NEW TAS A, NEW TAS C,
and NEW TAS E) were created with higher GC-content and
melting temperature to increase the efficiency of the PCR
(Table 1) and were labeled as per the name of the respective
TAS sequence used (Table 1). The annealing temperature was
calculated using the algorithm developed by Wu et. al., (1991)
and the melting temperatures were calculated using the Mac
Vector Software.
DNA Gel Electrophoresis
For a 1.5% gel, 1.5 g of agarose were dissolved in 100 ml of 1X
TBE (54.0 g of Tris Base, 27.5 g of Boric acid and 20 ml of 0.5
M EDTA {pH 8.0} in 1.0 L of nano pure H20) buffer by
microwaving. The agarose solution was then poured into the
gel tray containing the appropriate gel comb and was allowed to
solidify.  The gel tray was then kept on the gel box, and enough
1X TBE was added to cover the gel.  The respective DNA
solutions were added to each well with loading dye.  The gel
was run at the appropriate voltage (~95-120V) and time until
the loading dyes were seen next to positive end of the gel. The
gels were then stained with ethidium bromide and analyzed by
BioRad Versa Doc Imaging System and Quantity One
Software.
Transformation of T. thermophila and Isolation of Genomic
DNA
Transformation of T. thermophila was performed by
electroporation as described by Gaertig and Gorovsky (1992).
Cell lines CU428.1 were grown in PPYS-PSF media (2%
Protease peptone, 0.2% Bacto-Yeast Extract, 0.003%
Sequestrine with 500 µl of PSF {45 ml of sterile nano pure
water was added to a vial of lyophilized Pencilin/Streptomycin
(Sigma, St. Louis, MO)} followed by 5 ml of Fungizone; Gibco)
at 30°C, while shaking at 100 rpm for 48 hours. The cells were
then washed twice in 10 mM Tris-HCl buffer (pH 7.4), combined
in equal ratios, and shaken at 150 rpm at 30°C for another
12–18 hours to prevent the cells from pairing until a desired
time. Cells were washed again twice 10.5 hours later in 10 mM
Hepes buffer (pH 7.4). The cells were then transformed with
plasmid DNA containing the desired telomerase RNA template
mutation (43AA) purified from previously transformed
Escherichia coli cells using a BTX Electroporation
System/Electro Cell Manipulator 600 at settings previously
determined by Gaertig and Gorovsky (1992). Electroporated
cells were drugged with paromomycin (Sigma Chem Co., St.
Louis, MO) at a final concentration of 120 µg/ml to select for
transformed cells.
One ml of the transformed CU428.1 strains was
inoculated in 50 ml of PPYS-PSF media in a 250 ml conical
flask for ~48 hrs at 30°C. The 43AA genomic DNA was then
isolated (by Christina Christ `03, Lake Forest College, IL, USA)
from the cultures using the Genomic DNA Maxi Isolation Kit
supplied by Qiagen (Valencia, CA) and was run on a 1.5%
agarose gel to check the presence of the genomic DNA.
For creating the ideal positive control, PCR was conducted on
different mixtures of the artificial fusions and the 43AA genomic
DNA. The concentrations of their different dilutions are
summarized in Table 2.
Restriction Digestion of 43AA DNA
The 43AA DNA was digested with the restriction enzyme Mse I
(New England BioLabs; Beverly, MA). The digestion reaction
consisted of 10% NEB Buffer 2, 10% BSA, 7.5% Mse I, 25%
template and 47.5% of sterile nano pure water in a total
reaction volume of 20 µl at 37°C for ~24hrs. Mse I was selected
as restriction enzyme because of two reasons. Firstly, MseI’s
100
restriction site is ideal for templates that are AT- rich like T.
thermophila genome. Secondly, none of the TAS sequences
possessed a restriction site for MseI according to sequence
analysis conducted by Mac Vector software.
Table 1: The names, sequences, melting temperatures, length & GC content of the primers
Primer Name, Sequence (3`-5`) & Ability to from
Secondary Structures: Hair Pin, Primer Dimer and Self
Duplex
Length Annealing
Temperature (0C)
Melting
Temperature
(0C)
%
GC
TAS A:
AATAGGTATAGATTAGTACTGGC
Forms Self-Duplex
23 67.26 48.8 34.7
PRX TAS A:
ATGATTGCGAAGCATCATTAAC
Form hairpin and Self Duplex
22 65.80 59.1 25.0
TAS B:
AAATGATTTCTAAGTGATTATTAAC
Forms Self-Duplex
25 65.80 50.5 20.0
TAS C:
AAAATATTTATGGAAAAGTACAGG
Forms Self-Duplex
24 65.80 53.1 25.0
PRX TAS C:
GCCACTAGGTTGTGAGGAAC
Forms Self-Duplex
26 67.26 57.2 55.0
TAS D:
CGCAGAGCGAACTATTAATCC
Form hairpin and Self Duplex
21 67.26 59.0 47.6
TAS E:
GTTCCGAACAGCCAACAGCC
Forms Self-Duplex
20 68.72 65.3 60.0
TAS F:
CGCATAGTGATTATTAACCACG
Forms Self-Duplex
22 67.26 57.3 40.9
NEW TAS C:
GTTCCGAACAGCCACTAGGTTGTGAGGAACG
Form Hairpin and Self Duplex
31 92.08 75.1 54.8
NEW TAS E:
CAGCCAACAGCCAAAAGGTTCTGAGGAACG
Form Hairpin and Self Duplex
30 89.16 75.9 53.3
Table 2: Concentrations of the different dilutions of artificial fusions and 43AA genomic DNA
Type
Non-Diluted
(µg/ml)
1:10
Dilution
(µg/ml)
1:100
Dilution
(µg/ml)
1:1,000
Dilution
(µg/ml)
1:10,000
Dilution
(µg/ml)
1:100,000
Dilution
(µg/ml)
1:1,000,000
Dilution
(µg/ml)
C & A Ligate 205 20.5 2.05 2.05 x 10-1 2.05 x 10-2 2.05 x10-3 2.05 x10-4
43AA
Genomic DNA
1215 121.5 12.15 1.215 1.215 x 10-1 1.215 x 10-2 1.215 x10-3
Southern Blotting
The PCR products to be analyzed were run on a 1.5% agarose
gel and the gel was used for the following procedures:
a) Alkali Transfer gel Treatment Protocol- The gel was treated
with 0.125 M HCl for 10.0 minutes for depurination (Amersham
Biosciences, Piscataway, NJ). Enough 0.125 M HCl was added
to a tray containing the gel to cover it. After complete
depurination, as indicated by the change in the color of the
bromophenol dye from blue to yellow, the gel was submerged
for 30 minutes in fresh denaturation buffer (87.66 g of NaCl and
20 g of NaOH in 1.0 L of nano pure H2O) for denaturation
(Amersham Biosciences). The content of the gel was then
transferred to a Hybond-N+ membrane by Capillary Blotting
(Amersham Biosciences). The blot (Hybond-N+ membrane) was
then used for hybridization with a telomeric probe.
b) Hybridization - The blot was pre-hybridized by submerging in
hybridization buffer (1 mM EDTA, 7.0% of 1 M Na2HPO4 (pH
7.2), 7.0% of 20.0% SDS and 1% BSA) in a tray at 370C for 1 hr
(Church and Gilbert, 1984). For hybridization, the blot was
added to a hybridization jar containing the probe (Mix 1.0 µl of
oligonucleotide {5` end radiolabeled oligonucleotide, 5`-
(GGGGTTT)3}, 6.0 µl of sterile nano pure H2O, 1 µl of 10X
101
buffer, 1 µl of χ32P label, and 1 µl of kinase at 370C for 20
minutes) mixed with 3 ml of hybridization buffer (Church and
Gilbert, 1984) and was rotated gently in a hybridization oven at
550C (Kirk et. al., 1995) for ~16 hours.
c) Washing & Analysis- After hybridization, the blot was washed
with wash buffer (1 mM EDTA, 40Mm of 1 M Na2HPO4 (pH 7.2),
and 1% SDS in nano pure H2O) five times at 60
0C for 5 minutes
each. The blot was then analyzed for telomeric signals using
the BioRad Personal Molecular Imager and Quantity One
Software.
Cloning & Sequencing Fusion Fragments
The cloning of the fusion fragments was conducted using the
TA Cloning Kit (Invitrogen, Carlsbad, CA). PCR products to be
sequenced were cut out (QlAquick Gel Extraction Kit by
Qiagen; Valencia, CA), ligated to pUC19 plasmids (Invitrogen)
and were used for transforming One ShotR competent
Escherichia coli (E. coli) cells (Invitrogen, Carlsbad, CA) by
heat shocking. The plasmid DNA was then isolated (Qiagen
Plasmid Purification Kit; Valencia, CA) and verified for the
presence of the insert by restriction digest using EcoR V (New
England BioLabs; Beverly, MA) as recommended by Invitrogen.
The reaction recipe for the digestion consists of 76% sterile
nano pure water, 10% NEB Buffer 3 (New England BioLabs;
Beverly, MA), 10% BSA (New England BioLabs; Beverly, MA),
10% pUC19 plasmid, and 4% of EcoR V in a total reaction
volume of 20 µl. Plasmids with the inserts were sequenced at
the Sequencing Facility at University of Chicago, IL, USA.
Acknowledgement
I would like to express my deepest gratitude to my advisor Prof.
Karen E. Kirk with whom I conducted this study. I would like to
thank my student mentors Jennifer McGuire and Christina
Christ for their training and intellectual assistance and my
colleague Daniel McNabney who also helped me with various
experiments. I show my earnest appreciation to my Senior
Thesis Committee members Prof. Douglas B. Light and Prof.
Ronald Miller for their commitment and patience in critiquing
this manuscript. I also like to express my special thanks to Prof.
Douglas B. Light for helping me write this Senior Thesis, when
my advisor was away due to sickness. In addition, I thank Sara
Herrera, Keith Hartley, and Prof. Shubhik K. DebBurman for
peer reviewing this manuscript. Lastly, but not the least, I am
grateful to God (if he/she/it exists) in the development of this
project.
Disclaimer
Eukaryon is published by students at Lake Forest
College, who are solely responsible for its content. The
views expressed in Eukaryon do not necessarily reflect
those of the College.
References
Alberts Bruce, Alexander J, Julian L, Martin R, Keith R, Peter W. 1997.
Molecular Biology of the Cell. 4th ed. Garlnd Science Taylor & Francis
Group, NewYork: p. 263, 437.
Allsop RC, Vazri H, Patterson C, Goldestein S, Younglai EV, Futcher AB,
Greider CW, and Harley CB. 1992. Telomere length predicts replicative
capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA, 89, 10114-
10118.
Armstrong SJ, Christopher HF, and Gareth H. Jones. 2001. Nucleolus-
associated telomere clustering and pairing precede meiotic chromosome
synapsis in Arabidopsis thaliana. Journal of Cell Science, 114, 4207-4217.
Asai, DJ, and James DF. 2000. Methods in Cell Biology, Vol. 62.
Academic Press, New York: p. 138, 417.
Baumann P, and Cech TR. 2000. Protection of telomeres by the Ku
protein in fission yeast. Mol. Biol. Cell, 11, 3265-3275.
Barnes WM. 1992. The Fidelity of Taq Polymerase Catalyzing PCR is
Improved by an N-terminal Deletion. Gene, 112, 29-35.
Barnes WM. 1994. PCR Amplification of up to 35-kb DNA with High
Fidelity and High Yield from  Bacteriophage Templates. PNAS, 91, 2216-
2220.
Beasley EM, Richard MM, David RC, and Laura CL. Statistical Refinement
of Primer Design Parameters.” Edited by Innins, Michael A., David H.
Gelfand, and John J. Sninsky (1999). PCR Application, Protocols for
functional genomics. Academic Press, New York, 55-72.
Bechter OE, Zou Y, Shay JW, and Wright WE. 2003. Homologous
recombination in human telomerase-positive and ALT cells occurs with the
same frequency. EMBO Rep.,12, 1138-1143.
Bertuch A and Victoria L. 1998. Telomeres and double-strand
breaks:trying to make ends meet. Trends in Cell Biology, 8, 339-342.
Bhattacharya A and Blackburn EH. 1997. Aspergillus nidulans   maintains
short telomeres throughout development. Nucleic Acids Research, 25,
1426-1431.
Biessmann H. and  Mason J.M. 1997. Drosophila telomere elongation.
Chromosoma, 106, 53-67.
Blackburn EH. 2001. Switching and Signaling at the Telomeres. Cell, 106,
661-673.
Blackburn EH, and Joseph GG. 1978. A Tandem Repeated Sequence at
the Terminal of the Extrachromsomal Ribosomal RNA Genes in
Tetrahymena. J. Mol. Biol., 120, 33-53.
Breslauer KJ, Frank R, Blocker H, and Marky LA. 1986. Predicting duplex
stability from the base sequence. PNAS, 83, 3746-3750.
Broccoli D, Smogorzewska A, Chong L, and de Lange T. 1997. Human
telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat.
Genet, 17, 231-235.
Chan, Simon WL and Blackburn EH. 2003. Telomerase and ATM/Tel1p
Protect Telomeres from Nonhomologous End Joining. Mol. Cell, 11, 1379-
1387.
Chen Phil and Blackburn EH. 1998. Two Types of Telomeric Chromatin in
Tetrahymena thermophila. JMB, 280, 327-344.
Cheng Suzanne and Kolmodin LA. 1997. XL PCR amplification of Long
Targets from genomic DNA. PCR Cloning Protcols. edited by Bruce A.
White.  Humana Press, New Jersey, 17-29.
Chikashige Y, Ding DQ, Funabiki H, Haraguchi T, Mashiko S, Yanagida
M, and Hiraoka Y. 1994. Telomere-led premeiotic chromosome movement
in fission yeast.  Science. 264, 270-273.
Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J,
Paul Tempst, and de Lange T. 1995. A human telomeric protein.  Science,
270, 1663-1667.
Christ Christina. 2002. Cell Cycle Defects in Tetrahymena thermophila
telomere mutants. Senior Thesis, Biology Department, Lake Forest
College, IL, 60045.
Chua PR and Shirleen GR. 1997. Tam1, a telomere-associated meiotic
protein, functions in chromosome synapsis and crossover interference.
Genes & Development, 11, 1786-1800.
Church GM and Gilbert W. 1984. Genomic Sequencing. PNAS, 81, 1991-
1995.
Collins Kathleen and Leena G. 1998. The reverse transcriptase
component of the Tetrahymena telomerase ribonucleoprotein complex.
Proc. Natl. Acad. Sci. USA., 95, 8485-8490.
Conrad MN, Jocelyn H, Wright A, Wolf J, and Virginia AZ. 1990. RAP1
Protein interacts with Yeast telomeres In vivo: Overproduction alters
telomere structure and decreases chromosome stability. Cell, 63, 739-
750.
Conrad Michael N, Ana MD and Michael ED. 1997. Ndj1p, a Meiotic
Telomere Protein Required for Normal Chromosomes Synapsi and
Segregation in Yeast. Science, 276, 1252-1255.
Copper JP, Nimmo ER, Allshire RC, and Cech TR. 1997. Regulation of
telomere length and function by a Myb-domain protein in fission yeast.
Nature, 385, 744-747.
Craven RJ, Patricia WG, Margaret D, and Thomas DP. 2002. Regulation
of Genome Stability by TEL1 and MEC1, Yeast Homologs of the
Mammalian ATM and ATR Genes. Genetics, 161, 493-507.
Dandjinou AT, Dionne I, Gravel S, LeBel C, Parenteau J, and Wellinger
RJ. 1999. Cytological and functional aspects of telomere maintaninace.
Histo. Histopathol. 14, 517-524.
Dubrana K, Severine P and Susan MG. 2001. Turning telomere off and
on. Nucelus and gene expression, 281-289.
102
Erlich HA. ed. 1989. PCR Technology, Principles and Applications for
DNA Amplification. Stockton, New York.
Espejel Silvia, Sonia F, Sandra RP, Simon DB, Juan CC, and Maria AB.
2002. Mammalian Ku86 mediates chromosomal fusions and apoptosis
caused by critically short telomeres. THE EMBO Journal, 21, 2207-2219.
Evans SK, Alison AB, and Victoria L. 1999. Telomeres and telomerase: at
the end, it all comes together. Trends Cell Biol., 9, 329-331.
Evans SK and Victoria L. 2000. Positive and negative regulation of
telomerase access to the telomere. J. Cell Sci., 113, 3357-3364.
Ferreira MG and Julia PC. 2001. The Fission Yeast Taz1 Protein Protects
Chromosomes from Ku-Dependent End-to-End Fusions. Mol. Cell, 7, 55-
63.
Funabiki H, Iain H, Satoru U, and Mitsuhiro Y. 1993. Cell-Cycle-dependent
Specific Positioning and Clustering of Centromeres and Telomeres in
Fission Yeast.  The Journal of Cell Biology, 121, 961-976.
Gaertig J and Gorovsky MA. 1992. Efficient mass transformation of
Tetrahymena thermophila by electroporation of conjugants. PNAS, 19,
9196-9200.
Gasser SM. 2000. A Sense of the End. Science, 288, 1377-1379.
Gilley D, Hiromi TM, Prakash H, Akihiro K, Gloria CL, Mitsuo O, and
Davoid J. Chen. 2001. DNA-Pkcs is critical for telomere capping. PNAS,
98, 15084-15088.
Gilson P and Geoffrey IM. 1995. The chlorarachniophyte: a cell with two
different nuclei and two different telomeres. Chromosoma, 103, 635-641.
Greider CW and Blackburn EH. 1985. Identification of a Specific Telomere
Terminal Transferase Activity in Tetrahymena Extracts. Cell, 43, 405-413.
Greider CW and Blackburn EH. 1987. The telomere terminal transferae of
Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer
specificity. Cell, 51, 887-898.
Grieder CW. 1998. Telomerase activity, cell proliferation, and cancer.
PNAS, 95, 90-92.
Greider CW and Blackburn EH. 1989. A telomeric sequence in the RNA of
Tetrahymena telomerase required for telomere repeat synthesis. Nature,
337, 331-337.
Greider CW. 1999. Telomeres Do D-Loop-T-Loop. Cell, 97, 419-422.
Griffith JD, Laurey C, Soraya R, Rachel MS, Alessandro B, Heidi M and
de Lange T. 1999. Mammalian Telomeres End in a Large Duplex Loop.
Cell, 97, 503-514.
Gualberto A, Patrick RM and Walsh Kenneth. 1992. Nuclei acid specificity
of a vertebrate telomere-binding protein: evidence for G-G base pair
recognition at the core-binding site. Genes & Development, 6, 815-824.
Haber JE. 1999. Sir-Ku-itous Routes to Make Ends Meet. Cell, 97, 829-
832.
Hackett JA, David MF, and Carol WG. 2001. Telomere Dysfunction
Increases Mutation Rate and Genomic Instability.  Cell, 106, 275-286.
Harley CB, Futcher AB, and Carol WG. 1990. Telomeres shorten during
ageing of human fibroblasts. Nature, 345, 458-460.
Hayflick L, and Moorehead PS. 1961. The limited in vitro lifetime of human
diploid strains. Experimental Aging Research, 25, 614-636.
Henderson ER and Blackburn EH. 1989. An overhanging 3’ terminus is a
conserved feature of telomeres. Mol Cell. Biol., 9, 345-348.
Henderson ER, Hardin CC, Wlak SK, Tinoco I Jr. and Blackburn EH.
1987. Telomeric DNA Oligonucleotides form novel intramoleular structures
containing guanine-guanine base pairs. Cell, 51, 899-908.
Hsu HL, Gilley D, Blackburn EH, and Chen DJ. 1999. Ku is associated
with the telomere in mammals. PNAS, 96, 12454-12458.
Hsu HL, David G, Sanjeev AG, Hande MP, Beth A, Sahn HK, Gloria CL,
Judith C, Terumi KS, and David JC. 2000. Ku acts in a unique way at the
mammalian telomere to prevent end joining. Genes & Development, 14,
2807-2812.
Hung T, Mak K, and Fong K. 1990. A specificity enhancer for polymerase
chain reaction. Nucleic Acids Res., 18, 4953.
Innis MA, Gelfand DH, Sninsky JJ, and White TJ, eds. 1990. PCR
Protocols. A Guide to Methods and Applications. Academic, San Diego,
CA.
Innis MA, Gelfand DH, and Sninsky JJ, eds. 1999. PCR Applications:
Protocols for Functional Genomics. Academic Press, San Diego, 3-22.
Kilian A, Heller K, and Kleinhofs A. 1998. Development patterns of
telomerase activity in barley and maize. Plant Mol. Biol., 37, 621-628.
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL,
Coviello, GM, Wright WE, Weinrich, SL, and Shay JW. 1994. Specific
association of human telomerase activity with immortal cells and cancer.
Science, 266, 2011-2015.
Kirk KE, and Blackburn EH. 1995. An unusual sequence arrangement in
the telomeres of the germ-line micronucleus in Tetrahymena thermophila.
Genes & Development, 9, 59-71.
Kirk KE, Harmon BP, Reichardt IK, Sedat J, and Blackburn EH. (1997).
Block in anaphase chromosome separation due to a telomerase template
mutation. Science, 275,1478-1481.
Klobutcher LA, Swanton MT, Donini P, and Presctt DM. 1981. All gene-
sized DNA molecules in four species hypotrichs have the same terminal
sequence and an unusual 3’ terminus. Proc. Natl. Acad. Sci. USA, 78,
3015-3019.
Kolmodin LA, and Williams JF. 1997. PCR: Basic Principles and Routine
Practice. PCR Cloning Protcols. edited by Bruce A. White.  Humana
Press, New Jersey, 3-16.
Landre PA, Gelfand DH, and Watson RH. 1995. The use of co-solvents to
enhance amplification by the polymerase chain reaction. PCR Strategies,
Academics, San Diego, CA, 3-16.
Larson GP, Castanotto D, Rossi JJ, and Malafa MP. 1994. Isolation and
functional analysis of a Kluyveromyces lactis RAP1 homologue. Gene,
150, 35-41.
Lentz DS and Blackburn EH. 1990. Functional Evidence for an RNA
Template in Telomerase.  Science, 247, 546-552.
Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, and Cech
TR. 1997. Reverse transcriptase motifs in the catalytic subunit of
telomerase. Science, 276, 561-567.
Liti G and Edward JL. 2003. NEJ1 Prevents NHEJ-Dependent Telomere
Fusions in Yeast without Telomerase. Mol. Cell, 11, 1373-1378.
Liu L, Maria AB and David LK. 2002. Requirement of functional telomeres
for metaphase chromosome alignments and integrity of meiotic spindles.
EMBO reports, 3, 230-234.
Lundblad V, Szostak JW. 1989. A mutant with a defect in telomere
elongation leads to senescence in yeast. Cell, 57, 633-643.
Lundblad V, Blackburn EH. 1993. An alternative pathway for yeast
telomere maintenance rescues est1-senescence. Cell, 73, 347-360.
Lundbald V. 1999. Telomeres Keep on Rapping. Science, 288, 2141-
2142.
Lustig AJ, Stephen K and David S. 1990. Involvement of the Silencer and
UAS binding protein RAP1 in regulation of Telomere Length. Science,
250, 549-553.
Mangahas JL, Mary KA, Lisa S, and Virginia AZ. 2001. Repair of
Chromosome ends after Telomere Loss in Saccharomyces. Molecular
Biology of the Cell, 12, 4078-4079.
McClintock B. 1938. The fusion of broken chromosome ends of sister half-
chromatids following chromatid breakage at meiotic anaphases. Missouri
Agricultural Experiment Station Research Bulletin, 290, 1.
McClintock B. 1941. The stability of broken ends of chromosomes in Zea
mays. Genetics, 26, 234.
McEachern MJ and Blackburn EH. 1996. Cap-prevented recombination
between terminal telomeric repeat arrays (telomere CPR) maintains
telomeres in Kluyveromyces lactis lacking telomerase.  Genes Dev., 10,
1822-1834.
McEachern MJ, Anat K, Blackburn EH. 2000. Telomeres and their control.
Annu. Rev. Genet., 34, 331-358.
McEachern MJ, Shilpa I. 2001. Short Telomeres in Yeast Are Highly
Recombinogenic. Molecular Cell, 7, 695-704.
McEachern MJ, Shilpa I, Tracy BF and Blackburn EH. 2000. Telomere
fusions caused by mutating the terminal region of telomeric DNA.  PNAS,
97, 11409-11414.
McKenzie KE, Christopher BU and Saraswati S. 1999. Applications of
telomerase research in the fight against cancer. Molecular Medicine
Today, 5, 114-122.
103
Moreau A, Duez C, and Dusart J. 1994. Improvement of GC-rich template
amplification by inverse PCR. BioTechniques, 17, 232-234.
Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD,
Meyne J, Ratliff RL, and Wu JR.. 1988. A highly conserved repetitive DNA
sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
Proc Natl Acad Sci U S A. 85, 6622-6626.
Muller HJ. 1938. The remaking of chromosomes. Collecting Net 8, 182.
Muller HJ. Studies in Genetics. Indiana University Press, Bloomington, IL,
1962.
Multani AS, Ozen M, Sen S, Mandal AK, Price JE, Fan D, Randinsky R,
Ali-Osman F, Von Eschenbach AC, and Pathak S. 1999. Amplification of
telomeric DNA directly correlates with metastatic potential of human and
murine cancers of various histological origin. International Journal of
Oncology, 15, 423-429.
Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH,
Lingner J, Harley CB, and Cech TR. 1997. Telomerase catalytic subunit
homologs from fission yeast and human. Science, 277, 955-959.
Olovnikov AM. 1971. Principle of margnotomy in template synthesis of
polynucleotides. Doklady of Akademii Nauk SSR, 201, 1496-1499.
Petcherskaia M, McGuire J, Pherson JM, and Kirk KE. 2003. Loss of cap
structure causes mitotic defect in Tetrahymena thermophila telomerase
mutants. Chromosoma,111, 429-437.
Pherson J. 2000. Study of Mutant Telomeres and Telomerase in
Tetrahymena thermophila. Senior Thesis, Biology Department, Lake
Forest College, IL, 60045.
Richards EJ and Ausubel FM. 1988. Isolation of a higher eukaryotic
telomere from Arabidopsis thaliana. Cell, 53, 127-136.
Riha K and Shippen DE. 2003. Ku is required for telomeric C-rich strand
maintenance but not for end-to-end chromosomes fusions in Arabidopsis.
PNAS, 100, 611-615.
Sarkar G, Kaplner S, and Sommer SS. 1990. Formamide can dramatically
improve the specificity of PCR. Nucleic Acids Res., 18, 7465.
Shampay J and Blackburn EH. 1984. DNA Sequences of telomeres
maintained in yeast. Science, 247, 154-157.
Shiels PG, Alexander JK, Keith HS, Campell DW, Ian W, Alan C, and
Angelika ES. 1999. Analysis of telomere lengths in cloned sheep. Nature,
399, 316-317.
Shore D and Nasmyth K. 1987. Purification and cloning of a DNA binding
protein from yeast that binds to both silencer and activator elements. Cell,
51, 721-732.
Steensel B and de Lange T. 1997. Control of telomere length by the
human telomerc protein TRF1. Nature, 385, 740-743.
Steensel B and Smogorzewska A and de Lange T. 1998. TRF2 protects
human telomeres from end-to-end fusions. Cell, 92, 401-413.
Tong WM, Prakash MH, Peter ML, and Zhao QW. 2001. DNA Strand
Break-Sensing Molecule Poly (ADP-Ribose) Polymerase Cooperates with
p53 in Telomere Function, Chromosome Stability, and Tumor
Suppression. Molecular and Cellular Biology, 21, 4046-4054.
Vassetzky NS, Florence G, Christine B, Susan MG, and Eric G. 1999.
Taz1p and Teb1p, two telobox proteins in Schizosaccharomyces pombe,
recognize different telomere-related DNA sequences. Nucleic Acids
Research, 27, 4687-4694.
Watson JD. 1972. Origin of concatameric T7 DNA. Nature New Biology,
239, 197-201.
Winship PR. 1989. An improved method for directly sequencin PCR
amplification material using dimethyl sulfoxide. Nucleic Acids Res., 17,
1266.
Wirght WE, Tesmer VM, Liao ML, and Shajy JW. 1999. Normal human
telomeres are not late replicating. Exp. Cell Res., 251, 492-499.
Woodard J, Kaneshiro E, and Gorovsky MA. 1988. Cytochemical studies
on the problem of macronuclear subnuclei in Tetrahymena. Genetics, 70,
251.
Wu DY, Ugozzoli L, Pal BK, Qian J, and Wallace RB. 1991. The effect of
temperature and oligonucleotide primer length on the specificity and
efficiency of amplification by the polymerase chain reaction. DNA Cell
Biol., 10, 233-238.
Yao MC, and Gorovsky M. 1974. Comparison of the sequences of
macronuclear and miconuclear DNA of Tetrahymena pyriformis. Cell, 12,
121-132.
Yu GL, Bradley JD, Attardi LD, Blackburn EH. 1990. In vivo alteration of
telomere sequences and senescence caused by mutated Tetrahymena
telomerase RNAs. Nature, 344, 126-132.
Zangenberg G, Saiki RK, and Reynolds R. 1999. Multiplex PCR:
Optimization Guidelines. Edited by Innins, Michael A., David H. Gelfand,
and John J. Sninsky. PCR Application, Protocols for functional genomics.
Academic Press, New York, 73-94.
